Employees: 151
Size Gevo (GEVO) is a United States Materials company (Chemicals: Specialty) with a market value of $421M, the 2801st largest of 3,085 United States companies the cockpit tracks. Shares closed at $1.70 on 18 Nov 2026.
Performance Over six months the shares gained 3.7%, against -18.0% for the median peer and -2.2% for the United States market (cap-weighted) — 5th highest of 21 in its peer set.
Growth Revenue grew 80.1% over the last twelve months (peer median +8.0%); the operating margin is -10.8% (peer median 4.5%).
Valuation It trades at 24.8× forward earnings against a peer median of 16.5× (2nd most expensive of 8).
Capital Return on invested capital runs 13.6 points below its cost of capital (9.2% WACC).
Next results Next results expected around 11 Mar 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | $218M | $161M | $16.9M | $17.2M | $1.18M |
| Revenue growth | — | +849% | -2% | +1,364% | — |
| Gross profit | $91.8M | $48.5M | -$16.4M | -$17.8M | -$20.0M |
| EBITDA | $2.41M | $6.46M | -$67.6M | -$62.8M | -$69.6M |
| Net income | -$182M | -$33.8M | -$78.6M | -$66.2M | -$98.0M |
| Free cash flow | -$30.8M | -$43.5M | -$108M | -$108M | -$128M |
| Capital expenditure | $62.8M | $30.1M | $51.1M | $54.5M | $75.8M |
| Total debt | $171M | $168M | $70.6M | $70.2M | $69.7M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | GEVO | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | +50.4% | -10.3% | highest of 21 |
| 6-month return | +3.7% | -18.0% | 5th highest of 21 |
| Distance from 52-week high | -42.8% | -37.9% | 9th lowest of 21 |
| Revenue growth (TTM) | +80.1% | +8.0% | 2nd highest of 21 |
| Operating margin | -10.8% | 4.5% | lowest of 21 |
| Forward P/E | 24.8× | 16.5× | 2nd most expensive of 8 |
| ROIC minus cost of capital | -13.6 pp | -2.2 pp | lowest of 21 |
| Net debt / EBITDA | 43.0× | 1.8× | most indebted of 9 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Gevo GEVO | United States | $421M | +4% | +80% | -11% | 24.8× | n/a | n/a |
| Ellenbarrie Industrial Gases ELLEN.NS | India | $420M | 0% | +289% | 28% | 24.6× | 42.8% | +14.3% |
| Braskem S.A. Sponsored ADR Pfd BAK | United States | $421M | -82% | -1% | 1% | 1.6× | n/a | n/a |
| FuJian Nox Bellcow 300132.SZ | China | $422M | -32% | +18% | 7% | 16.5× | -4.3% | -10.5% |
| Koatsu Gas Kogyo 4097.T | Japan | $423M | +10% | +4% | 7% | n/a | -9.6% | +5.1% |
| Nantong Jiangtian Chemical 300927.SZ | China | $425M | -32% | +51% | 5% | n/a | 16.3% | +29.0% |
| Guangdong Tianan New Material 603725.SS | China | $425M | -10% | -12% | 2% | n/a | 19.4% | +29.0% |
| Shanghai Huide Science & Technology 603192.SS | China | $426M | -22% | +10% | 3% | n/a | 9.0% | +10.5% |
| Tatva Chintan Pharma Chem TATVA.NS | India | $412M | +29% | +50% | 13% | 49.8× | n/a | n/a |
| Guangdong Delian 002666.SZ | China | $410M | -30% | +3% | 0% | n/a | n/a | n/a |
| Oriental Union Chemical 1710.TW | Taiwan | $409M | +41% | +1% | 0% | 16.1× | n/a | n/a |
| Baotou Dongbao Bio-Tech 300239.SZ | China | $408M | -14% | +7% | 7% | n/a | n/a | n/a |
| UPC Technology 1313.TW | Taiwan | $435M | +9% | -1% | 0% | n/a | 38.2% | +2.5% |
| KPIC 006650.KS | South Korea | $405M | -40% | +11% | 4% | 8.9× | n/a | n/a |
| Zhejiang Haisen Pharmaceutical 001367.SZ | China | $404M | -24% | +9% | 29% | n/a | -3.9% | +13.4% |
| Zhejiang Jianye Chemical 603948.SS | China | $438M | -36% | -5% | 12% | n/a | -4.3% | +3.5% |
| Qingdao Copton Technology 603798.SS | China | $401M | -43% | -7% | 5% | n/a | 19.9% | +0.9% |
| Shenyang Chemical Industry 000698.SZ | China | $443M | -4% | +18% | 1% | n/a | n/a | n/a |
| Changhua Chemical Technology 301518.SZ | China | $443M | -44% | +17% | -2% | n/a | n/a | n/a |
| Hubei Shuanghuan Science and Technology 000707.SZ | China | $399M | -11% | -10% | -10% | n/a | 56.5% | +3.1% |
| Vishnu Chemicals VISHNU.NS | India | $398M | -8% | +14% | 13% | 20.1× | n/a | n/a |